...
search icon
slgl-img

Sol Gel Technologies Ltd, Common Stock

SLGL

NAQ

$0.61

+$0.02

(3.39%)

1D
Industry: Pharmaceuticals Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$16.42M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
30.65K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
1.31
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$0.33 L
$1.65 H
$0.61

About Sol Gel Technologies Ltd, Common Stock

Sol-Gel Technologies Ltd., together with its subsidiary Sol-Gel Technologies Inc., develops topical dermatological drugs for patients with severe skin conditions in Israel. The company offers Twyneo, a once-daily, non-antibiotic topical cream for the treatment of acne vulgaris; and Epsolay, a once-daily topical cream for the treatment of papulopustular (subtype II) rosacea. It also develops SGT-610 that is in Phase 3 clinical trials for the treatment of Gorlin Syndrome; and SGT-210, which has completed Phase I clinical trial, to treat rare hyperkeratinization disorders, such as Darier, PC, PPK, Olmsted, etc. In addition, the company is also involved in the development of generic topical dermatological drug products. It has collaboration with Padagis Israel Pharmaceuticals Ltd; and license agreements with Galderma Holding SA and Searchlight Pharma Inc. Sol-Gel Technologies Ltd. was incorporated in 1997 and is headquartered in Ness Ziona, Israel. more

Industry: PharmaceuticalsSector: Health Care

Returns

Time FrameSLGLSectorS&P500
1-Week Return-1.31%0.54%0.54%
1-Month Return-32.32%3.28%1.66%
3-Month Return37.87%3.01%3.83%
6-Month Return35.41%-4.69%9.77%
1-Year Return-48.91%1.41%23.47%
3-Year Return-91.67%15.72%42.73%
5-Year Return-94.9%42.38%82.01%
10-Year Return-95.54%103.91%190.88%

Financials

Dec '19Dec '20Dec '21Dec '22Dec '235YR TREND
Total Revenue22.90M8.77M31.27M3.88M1.55M[{"date":"2019-12-31","value":73.24,"profit":true},{"date":"2020-12-31","value":28.05,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":12.42,"profit":true},{"date":"2023-12-31","value":4.97,"profit":true}]
Cost of Revenue40.58M27.91M20.38M12.68M23.54M[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":68.79,"profit":true},{"date":"2021-12-31","value":50.23,"profit":true},{"date":"2022-12-31","value":31.25,"profit":true},{"date":"2023-12-31","value":58.01,"profit":true}]
Gross Profit(17.67M)8.77M10.89M(8.80M)(21.99M)[{"date":"2019-12-31","value":-162.28,"profit":false},{"date":"2020-12-31","value":80.53,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-80.79,"profit":false},{"date":"2023-12-31","value":-201.88,"profit":false}]
Gross Margin(77.17%)100.00%34.83%(226.60%)(1414.86%)[{"date":"2019-12-31","value":-77.17,"profit":false},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":34.83,"profit":true},{"date":"2022-12-31","value":-226.6,"profit":false},{"date":"2023-12-31","value":-1414.86,"profit":false}]
Operating Expenses48.85M39.00M28.31M20.13M30.86M[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":79.84,"profit":true},{"date":"2021-12-31","value":57.94,"profit":true},{"date":"2022-12-31","value":41.2,"profit":true},{"date":"2023-12-31","value":63.17,"profit":true}]
Operating Income25.95M(30.23M)2.08M(16.24M)(29.30M)[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":-116.5,"profit":false},{"date":"2021-12-31","value":8.03,"profit":true},{"date":"2022-12-31","value":-62.6,"profit":false},{"date":"2023-12-31","value":-112.93,"profit":false}]
Total Non-Operating Income/Expense(49.15M)1.89M514.00K2.64M3.98M[{"date":"2019-12-31","value":-1234.04,"profit":false},{"date":"2020-12-31","value":47.35,"profit":true},{"date":"2021-12-31","value":12.9,"profit":true},{"date":"2022-12-31","value":66.33,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Pre-Tax Income(24.58M)(29.29M)3.22M(14.92M)(27.24M)[{"date":"2019-12-31","value":-762.99,"profit":false},{"date":"2020-12-31","value":-909.34,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-463.3,"profit":false},{"date":"2023-12-31","value":-845.64,"profit":false}]
Income Taxes33.00K(1.89M)(1.14M)(1.32M)(1.00)[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":-5724.24,"profit":false},{"date":"2021-12-31","value":-3445.45,"profit":false},{"date":"2022-12-31","value":-4003.03,"profit":false},{"date":"2023-12-31","value":"-","profit":true}]
Income After Taxes(24.61M)(27.40M)4.36M(13.60M)(27.24M)[{"date":"2019-12-31","value":-564.69,"profit":false},{"date":"2020-12-31","value":-628.75,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-312.12,"profit":false},{"date":"2023-12-31","value":-625.01,"profit":false}]
Income From Continuous Operations(24.61M)(29.29M)3.22M(14.92M)(28.19M)[{"date":"2019-12-31","value":-764.02,"profit":false},{"date":"2020-12-31","value":-909.34,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-463.3,"profit":false},{"date":"2023-12-31","value":-875.1,"profit":false}]
Income From Discontinued Operations-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income(24.61M)(27.40M)4.36M(13.60M)(27.24M)[{"date":"2019-12-31","value":-564.69,"profit":false},{"date":"2020-12-31","value":-628.75,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-312.12,"profit":false},{"date":"2023-12-31","value":-625.01,"profit":false}]
EPS (Diluted)(1.26)(1.29)0.13(0.65)(1.01)[{"date":"2019-12-31","value":-969.23,"profit":false},{"date":"2020-12-31","value":-992.31,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-500,"profit":false},{"date":"2023-12-31","value":-776.92,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

SLGL
Cash Ratio 4.29
Current Ratio 5.81

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

SLGL
ROA (LTM) -15.24%
ROE (LTM) -24.59%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

SLGL
Debt Ratio Lower is generally better. Negative is bad. 0.19
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.81

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

SLGL
Trailing PE NM
Forward PE 9.34
P/S (TTM) 1.40
P/B 0.48
EV/R 0.21
EV/Ebitda 0.24

FAQs

What is Sol Gel Technologies Ltd share price today?

Sol Gel Technologies Ltd (SLGL) share price today is $0.61

Can Indians buy Sol Gel Technologies Ltd shares?

Yes, Indians can buy shares of Sol Gel Technologies Ltd (SLGL) on Vested. To buy Sol Gel Technologies Ltd from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in SLGL stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Sol Gel Technologies Ltd be purchased?

Yes, you can purchase fractional shares of Sol Gel Technologies Ltd (SLGL) via the Vested app. You can start investing in Sol Gel Technologies Ltd (SLGL) with a minimum investment of $1.

How to invest in Sol Gel Technologies Ltd shares from India?

You can invest in shares of Sol Gel Technologies Ltd (SLGL) via Vested in three simple steps:

  • Click on Sign Up or Invest in SLGL stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Sol Gel Technologies Ltd shares
What is Sol Gel Technologies Ltd 52-week high and low stock price?

The 52-week high price of Sol Gel Technologies Ltd (SLGL) is $1.65. The 52-week low price of Sol Gel Technologies Ltd (SLGL) is $0.33.

What is Sol Gel Technologies Ltd price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Sol Gel Technologies Ltd (SLGL) is 0.48

What is the Market Cap of Sol Gel Technologies Ltd?

The market capitalization of Sol Gel Technologies Ltd (SLGL) is $16.42M

What is Sol Gel Technologies Ltd’s stock symbol?

The stock symbol (or ticker) of Sol Gel Technologies Ltd is SLGL

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top